Johnson & Johnson is leading the charge when it comes to reconnecting health & care—blending innovations in medicine and technology with personalized solutions that put the patient at the center.
As part of this mission to prioritize patients, the company has just released the 2023 Johnson & Johnson U.S. Pricing Transparency Report. In its eighth year, the report continues the company’s legacy of providing key data, analysis and insights that will help advance solutions to create a more sustainable, equitable and innovative healthcare system.
“At Johnson & Johnson, we take pride in pioneering cures and treatments that provide hope for patients,” says Tom Cavanaugh, Company Group Chairman, North America. “The American medical innovation ecosystem will continue advancing health more in the next decade than in the last century—as long as policies at the U.S. federal and state level put patient healthcare needs first. The eighth edition of our U.S. Pricing Transparency Report, now live, provides data and insights for a more sustainable, equitable and innovative healthcare system.”
Some key takeaways from the report:
Everything Johnson & Johnson does is guided by Our Credo, which states that the company’s first responsibility is to “the patients, doctors and nurses, to mothers and fathers and all others who use our products and services.” We believe that respect for individual patient values must be center stage in any solution and any value assessment.
